Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CheelcareTSXV:CHER 6 5-Year Yield-on-Cost % is 0.00 as of Sep. 07, 2026. GuruFocus rates TSXV:CHER with a GF Score™ of 6/100. The stock has 6 warning signs investors should review. Among 314 Medical Devices & Instruments companies, Cheelcare ranks worse than 318471.02% on this metric.
Cheelcare's yield on cost for the quarter that ended in Apr. 2026 was 0.00.
The historical rank and industry rank for Cheelcare's 5-Year Yield-on-Cost % or its related term are showing as below:
TSXV:CHER's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.46 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Cheelcare 5-Year Yield-on-Cost % Related Terms
TSXV:CHER vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Cheelcare's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cheelcare 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cheelcare's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Cheelcare's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Cheelcare is calculated as
Cheelcare (TSXV:CHER) has a 5-Year Yield-on-Cost % of 0.00 as of Sep. 07, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Cheelcare and its competitors. According to the industry distribution chart, Cheelcare ranks #999999 out of 314 companies in the Medical Devices & Instruments industry.
Is Cheelcare's 5-Year Yield-on-Cost % too high?
Cheelcare's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Cheelcare ranks #999999 out of 314 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Cheelcare has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Cheelcare's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cheelcare ranks #999999 out of 314 companies for 5-Year Yield-on-Cost %. This places Cheelcare in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.46. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.46, based on 314 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Cheelcare and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cheelcare's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cheelcare stock overvalued right now?
Cheelcare (TSXV:CHER) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. Cheelcare's overall GF Score™ is 6/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Cheelcare (TSXV:CHER), the current 5-Year Yield-on-Cost % is 0.00 as of Sep. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cheelcare Inc is a company that designs and manufactures inventive mobility devices using robotics. Its product portfolio consists of three key lines: Robotic Complex Rehab Power Wheelchair such devices feature patented self-leveling technology and the lowest seat-to-floor height in their class, enhancing stability and accessibility. Power Add-ons for Manual Wheelchairs designed to convert manual wheelchairs into powered mobility devices, offering users increased independence. Aftermarket Wheelchair Accessories includes a range of OEM equipment, backup cameras, phone chargers, and wheel suspension systems, that allow wheelchair users the ability to supplement their existing equipment to improve safety and convenience.
6GF Score
Get the complete analysis for TSXV:CHER
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:CHER has been successfully added to your 
